Rize Oncology Inc.
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -170.20K | -128.70K | -107.80K | -144.20K | -316.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.90K | 20.10K | 1.90K | 3.50K | 237.20K |
| Change in Net Operating Assets | 73.10K | 29.70K | -103.40K | 62.00K | 52.80K |
| Cash from Operations | -99.00K | -79.00K | -209.30K | -78.70K | -26.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 347.50K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 347.50K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -52.60K | 13.90K | -12.10K | -32.20K | 28.30K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Net Change in Cash | 195.90K | -65.10K | -221.40K | -110.90K | 2.10K |